Role of autophagy in Parkinson's disease
S Cerri, F Blandini - Current medicinal chemistry, 2019 - ingentaconnect.com
Autophagy is an essential catabolic mechanism that delivers misfolded proteins and
damaged organelles to the lysosome for degradation. Autophagy pathways include …
damaged organelles to the lysosome for degradation. Autophagy pathways include …
[HTML][HTML] Mitochondria: a therapeutic target for Parkinson's disease?
Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The
exact causes of neuronal damage are unknown, but mounting evidence indicates that …
exact causes of neuronal damage are unknown, but mounting evidence indicates that …
[HTML][HTML] ER lipid defects in neuropeptidergic neurons impair sleep patterns in Parkinson's disease
JS Valadas, G Esposito, D Vandekerkhove… - Neuron, 2018 - cell.com
Parkinson's disease patients report disturbed sleep patterns long before motor dysfunction.
Here, in parkin and pink1 models, we identify circadian rhythm and sleep pattern defects …
Here, in parkin and pink1 models, we identify circadian rhythm and sleep pattern defects …
[HTML][HTML] Neurodegenerative disorders: Spotlight on sphingolipids
F Mandik, M Vos - International Journal of Molecular Sciences, 2021 - mdpi.com
Neurodegenerative diseases are incurable diseases of the nervous system that lead to a
progressive loss of brain areas and neuronal subtypes, which is associated with an increase …
progressive loss of brain areas and neuronal subtypes, which is associated with an increase …
[HTML][HTML] Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease
Background Most sequencing studies in Parkinson's disease (PD) have focused on either a
particular gene, primarily in familial and early onset PD samples, or on screening single …
particular gene, primarily in familial and early onset PD samples, or on screening single …
Developing DNA methylation-based diagnostic biomarkers
An emerging paradigm shift for disease diagnosis is to rely on molecular characterization
beyond traditional clinical and symptom-based examinations. Although genetic alterations …
beyond traditional clinical and symptom-based examinations. Although genetic alterations …
[HTML][HTML] Parkinson's disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons
Background Parkinson's disease (PD)-associated E3 ubiquitin ligase Parkin is enriched at
glutamatergic synapses, where it ubiquitinates multiple substrates, suggesting that its …
glutamatergic synapses, where it ubiquitinates multiple substrates, suggesting that its …
Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular …
A Lamine, M Létourneau, ND Doan, J Maucotel… - …, 2016 - Elsevier
Parkinson's disease (PD) is characterized by a steady loss of dopamine neurons through
apoptotic, inflammatory and oxidative stress processes. In that line of view, the pituitary …
apoptotic, inflammatory and oxidative stress processes. In that line of view, the pituitary …
[HTML][HTML] Role of ceramides and sphingolipids in Parkinson's disease
Sphingolipids, including the basic ceramide, are a subset of bioactive lipids that consist of
many different species. Sphingolipids are indispensable for proper neuronal function, and …
many different species. Sphingolipids are indispensable for proper neuronal function, and …
[HTML][HTML] Inhibition of oxidative stress in cholinergic projection neurons fully rescues aging-associated olfactory circuit degeneration in Drosophila
A Hussain, A Pooryasin, M Zhang, LF Loschek… - Elife, 2018 - elifesciences.org
Loss of the sense of smell is among the first signs of natural aging and neurodegenerative
diseases such as Alzheimer's and Parkinson's. Cellular and molecular mechanisms …
diseases such as Alzheimer's and Parkinson's. Cellular and molecular mechanisms …